CLHIA-ACCAP

Canadian Life and Health Insurance Facts -- 2018

Issue link: http://clhia.uberflip.com/i/1030763

Contents of this Issue

Navigation

Page 18 of 24

Contents View provincial data View historical data Specialty drugs The development of specialized drugs has also led to a steep rise in drug costs. These specialty drugs, while making up 2% of the total number of claims, accounted for 31% of prescription drug costs in 2017, and the costs are expected to rise further in future years. 13 2017 health benefits $34.0B Ext. health 75% Disability 21% Other 4% Benefits by coverage type $11.3B Drugs $8.1B Dental $3.4B Paramedical* & vision Ext. health $1.8B Hospital $0.9B Travel *Refers to services and professions, such as physiotherapy, that supplement and support medical treatment The cost of specialty drugs is anticipated to reach 40% of prescription drug costs by 2022* 22% 31% 40% 2012 2017 2022 (estimated) *Source: Drug Trend Report, Express Scripts Canada 87% paid out to policyholder as benefits 7% operating costs 3% taxes 3% profit The above demonstrates how health premiums are put to work, providing value to consumers (5-year average) Cost-effective health protection

Articles in this issue

Links on this page

view archives of CLHIA-ACCAP - Canadian Life and Health Insurance Facts -- 2018